Cite
HARVARD Citation
Cefalù, A. et al. (2022). Lomitapide effectively reduces triglyceride (TG) levels in familial chylomicronemia syndrome (FCS). Atherosclerosis. pp. 45-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cefalù, A. et al. (2022). Lomitapide effectively reduces triglyceride (TG) levels in familial chylomicronemia syndrome (FCS). Atherosclerosis. pp. 45-. [Online].